Is Agenus (NASDAQ: AGEN) Stock A Good Buy?
Shares of Agenus Inc. traded up 23.87% on Thursday before the company earlier announced an oral presentation at the upcoming European Society of Medical Oncology (ESMO) Conference on September 18, 2020. Previously, it has disclosed that it will present the data from Phase 2 trials of balstilimab alone and in combination with zalifrelimab in ESMO […]
Is Agenus (NASDAQ: AGEN) Stock A Good Buy? Read More »